You are here

Article Text

Article menu

Download PDFPDF

Chronic obstructive pulmonary disease
Familial aggregation of FEF25–75 and FEF25–75/FVC in families with severe, early onset COPD
Free
  1. D L DeMeo1,2,3,
  2. V J Carey1,
  3. H A Chapman5,
  4. J J Reilly2,3,
  5. L C Ginns4,
  6. F E Speizer1,3,
  7. S T Weiss1,3,
  8. E K Silverman1,2,3
  1. 1Channing Laboratory, Brigham and Women’s Hospital, Boston, MA, USA
  2. 2Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
  3. 3Harvard Medical School, Boston, MA, USA
  4. 4Pulmonary and Critical Care Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
  5. 5Cardiovascular Research Institute, Department of Medicine, University of California at San Francisco, San Francisco, CA, USA
  1. Correspondence to:
    Dr D L DeMeo
    Channing Laboratory, Pulmonary & Critical Care Division, Brigham and Women’s Hospital, Harvard Medical School, 181 Longwood Ave, Boston, MA 02115, USA; redldchanning.harvard.edu

Abstract

Background: The Boston Early-Onset COPD study showed that current or ex-smoking first degree relatives of severe early onset COPD probands have significantly lower forced expiratory volume in 1 second (FEV1) and FEV1/forced vital capacity (FVC) values than current or ex-smoking control subjects, which suggests the existence of genetic risk factors for the development of COPD in response to cigarette smoking. We hypothesised that first degree relatives of early onset COPD probands may also have lower values of spirometric parameters such as forced expiratory flow at the mid-portion of forced vital capacity (FEF25–75) and FEF25–75/FVC.

Methods: Using generalised estimating equations, FEF25–75 and FEF25–75/FVC were analysed in 333 first degree relatives of probands with severe early onset COPD and 83 population based controls; analyses were also performed on data stratified by smoking status. Narrow sense heritability estimates were calculated using a variance component approach.

Results: Significantly lower FEF25–75 and FEF25–75/FVC were observed in smoking (FEF25–75: β −0.788 l/s (95% CI −1.118 to −0.457), FEF25–75/FVC: β −20.4% (95% CI −29.3 to −11.6, p<0.0001 for both phenotypes) and non-smoking (FEF25–75: β −0.357 l/s (95% CI −0.673 to −0.041, p = 0.0271), FEF25−75/FVC: β −9.5% (95% CI −17.1 to −1.9, p = 0.0145)) first degree relatives of early onset COPD probands. Narrow sense heritability estimates for FEF25–75 (h2 = 0.38) and FEF25–75/FVC (h2 = 0.45) were similar to those for FEV1 and FEV1/FVC.

Conclusion: Lower values of FEF25–75 and FEF25–75/FVC in non-smoking first degree relatives of early onset COPD probands than in controls suggest a genetic susceptibility to develop obstructive lung disease, independent of smoking, which is magnified by exposure to deleterious environments as suggested by the further decrements in FEF25–75 and FEF25–75/FVC seen in smoking first degree relatives. FEF25–75 and FEF25–75/FVC have high heritability and are important intermediate phenotypes for inclusion in genetic epidemiological studies of COPD.

  • chronic obstructive pulmonary disease
  • smoking
  • genetics
  • lung function
  • FEF25–75, forced expiratory flow at the mid-portion of forced vital capacity
  • FEV1, forced expiratory volume in 1 second
  • FVC, forced vital capacity

https://doi.org/10.1136/thx.2003.012856

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Dr DeMeo was supported by National Institute of Health (NIH) grant T32 HL0742722. The Boston Early-Onset COPD Study was supported by NIH grant R01 HL61575.